198 related articles for article (PubMed ID: 17963427)
1. Alkylation activity and molecular properties of two antineoplastic agents that utilise indometacin and a conjugate of aspirin with 2-aminonicotinic acid to transport nitrogen mustard groups.
Bartzatt R
Drugs R D; 2007; 8(6):363-72. PubMed ID: 17963427
[TBL] [Abstract][Full Text] [Related]
2. Bifunctional constructs of aspirin and ibuprofen (non-steroidal anti-inflammatory drugs; NSAIDs) that express antibacterial and alkylation activities.
Bartzatt R; Cirillo SL; Cirillo JD; Donigan L
Biotechnol Appl Biochem; 2003 Jun; 37(Pt 3):273-82. PubMed ID: 12533193
[TBL] [Abstract][Full Text] [Related]
3. Utilizing a D-amino acid as a drug carrier for antineoplastic nitrogen mustard groups.
Bartzatt RL
Drug Deliv; 2005; 12(3):141-7. PubMed ID: 16025843
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and alkylation activity of a nitrogen mustard agent to penetrate the blood-brain barrier.
Bartzatt RL
Drug Deliv; 2004; 11(1):19-26. PubMed ID: 15168787
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of aromatic nitrogen mustard agents and analysis of their alkylation activity at physiological pH and temperature.
Bartzatt R; Kasher L
Physiol Chem Phys Med NMR; 2002; 34(2):103-17. PubMed ID: 12841328
[TBL] [Abstract][Full Text] [Related]
6. A bifunctional alkylating nitrogen mustard agent that utilizes barbituric acid as carrier drug with the potential for crossing the brain-blood barrier.
Bartzatt R; Donigan L
Recept Channels; 2003; 9(5):309-13. PubMed ID: 14527874
[TBL] [Abstract][Full Text] [Related]
7. Sequence specificity of alkylation for a series of nitrogen mustard-containing analogues of distamycin of increasing binding site size: evidence for increased cytotoxicity with enhanced sequence specificity.
Wyatt MD; Lee M; Garbiras BJ; Souhami RL; Hartley JA
Biochemistry; 1995 Oct; 34(40):13034-41. PubMed ID: 7548062
[TBL] [Abstract][Full Text] [Related]
8. A New Cross-Link for an Old Cross-Linking Drug: The Nitrogen Mustard Anticancer Agent Mechlorethamine Generates Cross-Links Derived from Abasic Sites in Addition to the Expected Drug-Bridged Cross-Links.
Nejad MI; Johnson KM; Price NE; Gates KS
Biochemistry; 2016 Dec; 55(50):7033-7041. PubMed ID: 27992994
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, DNA interactions and biological activity of DNA minor groove targeted polybenzamide-linked nitrogen mustards.
Atwell GJ; Yaghi BM; Turner PR; Boyd M; O'Connor CJ; Ferguson LR; Baguley BC; Denny WA
Bioorg Med Chem; 1995 Jun; 3(6):679-91. PubMed ID: 7582946
[TBL] [Abstract][Full Text] [Related]
10. The mechanism of guanine alkylation by nitrogen mustards: a computational study.
Polavarapu A; Stillabower JA; Stubblefield SG; Taylor WM; Baik MH
J Org Chem; 2012 Jul; 77(14):5914-21. PubMed ID: 22681226
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic journery of nitrogen mustard as alkylating anticancer agents: Historic to future perspectives.
Singh RK; Kumar S; Prasad DN; Bhardwaj TR
Eur J Med Chem; 2018 May; 151():401-433. PubMed ID: 29649739
[TBL] [Abstract][Full Text] [Related]
12. New thymine-based derivative of nitrogen mustards.
Boëns B; Teste K; Hadj-Bouazza A; Ismaili J; Zerrouki R
Nucleosides Nucleotides Nucleic Acids; 2012; 31(3):197-205. PubMed ID: 22356235
[TBL] [Abstract][Full Text] [Related]
13. Novel DNA-directed alkylating agents consisting of naphthalimide, nitrogen mustard and lexitropsin moieties: synthesis, DNA sequence specificity and biological evaluation.
Gupta R; Liu J; Xie G; Lown JW
Anticancer Drug Des; 1996 Dec; 11(8):581-96. PubMed ID: 9022747
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia-selective antitumor agents. 12. Nitrobenzyl quaternary salts as bioreductive prodrugs of the alkylating agent mechlorethamine.
Tercel M; Wilson WR; Anderson RF; Denny WA
J Med Chem; 1996 Mar; 39(5):1084-94. PubMed ID: 8676343
[TBL] [Abstract][Full Text] [Related]
15. Aziridinium ion ring formation from nitrogen mustards: mechanistic insights from ab initio dynamics.
Mann DJ
J Phys Chem A; 2010 Apr; 114(13):4486-93. PubMed ID: 20222705
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and reactivity of aryl nitrogen mustard-oligodeoxyribonucleotide conjugates.
Reed MW; Lukhtanov EA; Gorn V; Kutyavin I; Gall A; Wald A; Meyer RB
Bioconjug Chem; 1998; 9(1):64-71. PubMed ID: 9460548
[TBL] [Abstract][Full Text] [Related]
17. Chemical factors in the action of phosphoramidic mustard alkylating anticancer drugs: roles for computational chemistry.
Colvin ME; Sasaki JC; Tran NL
Curr Pharm Des; 1999 Aug; 5(8):645-63. PubMed ID: 10469896
[TBL] [Abstract][Full Text] [Related]
18. Quantum molecular modeling of the interaction between guanine and alkylating agents--2--nitrogen mustard.
Hamza A; Broch H; Vasilescu D
J Biomol Struct Dyn; 1996 Jun; 13(6):915-24. PubMed ID: 8832374
[TBL] [Abstract][Full Text] [Related]
19. Chlorambucil-adducts in DNA analyzed at the oligonucleotide level using HPLC-ESI MS.
Mohamed D; Mowaka S; Thomale J; Linscheid MW
Chem Res Toxicol; 2009 Aug; 22(8):1435-46. PubMed ID: 19621941
[TBL] [Abstract][Full Text] [Related]
20. The role of base excision repair in the repair of DNA adducts formed by a series of nitrogen mustard-containing analogues of distamycin of increasing binding site size.
Brooks N; McHugh PJ; Lee M; Hartley JA
Anticancer Drug Des; 1999 Feb; 14(1):11-8. PubMed ID: 10363024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
